Bispecific t cell engager and uses thereof
AssigneeManysmart Therapeutics, Inc.
InventorsHSIN-YI HUANG, Cheng Hao LIAO
Life of this patent
Estimating the term…
Abstract
A novel fusion protein to overcome the current difficulties related to application of monoclonal antibodies in disease treatment and in other fields, particularly those requiring ADCC, e.g. for depletion of tumor cells, virally-infected cells, or immune-modulating cells, etc. One example of the fusion protein is an extracellular domain of a high-affinity variant of human CD 16 A fused to an anti-CD3 antibody or its antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.
Claims25
A fusion protein comprising:
- an extracellular domain of human CD16A;
- and
- an antibody or antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.